129 related articles for article (PubMed ID: 7650377)
1. HLA-DQ polymorphisms are highly selective for peptide binding interactions.
Kwok WW; Nepom GT; Raymond FC
J Immunol; 1995 Sep; 155(5):2468-76. PubMed ID: 7650377
[TBL] [Abstract][Full Text] [Related]
2. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
Buckner J; Kwok WW; Nepom B; Nepom GT
J Immunol; 1996 Dec; 157(11):4940-5. PubMed ID: 8943399
[TBL] [Abstract][Full Text] [Related]
3. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
[TBL] [Abstract][Full Text] [Related]
4. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
[TBL] [Abstract][Full Text] [Related]
5. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation.
Kwok WW; Kovats S; Thurtle P; Nepom GT
J Immunol; 1993 Mar; 150(6):2263-72. PubMed ID: 8450211
[TBL] [Abstract][Full Text] [Related]
6. Trans-encoded DQ alpha beta heterodimers confer susceptibility to myasthenia gravis disease.
Khalil I; Berrih-Aknin S; Lepage V; Loste MN; Gajdos P; Hors J; Charron D; Degos L
C R Acad Sci III; 1993 Jul; 316(7):652-60. PubMed ID: 8019886
[TBL] [Abstract][Full Text] [Related]
7. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQB1 codon 57 is critical for peptide binding and recognition.
Kwok WW; Domeier ME; Johnson ML; Nepom GT; Koelle DM
J Exp Med; 1996 Mar; 183(3):1253-8. PubMed ID: 8642268
[TBL] [Abstract][Full Text] [Related]
9. Definition of a DQ3.1-specific binding motif.
Sidney J; Oseroff C; del Guercio MF; Southwood S; Krieger JI; Ishioka GY; Sakaguchi K; Appella E; Sette A
J Immunol; 1994 May; 152(9):4516-25. PubMed ID: 7512598
[TBL] [Abstract][Full Text] [Related]
10. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus.
Ettinger RA; Kwok WW
J Immunol; 1998 Mar; 160(5):2365-73. PubMed ID: 9498778
[TBL] [Abstract][Full Text] [Related]
11. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
[TBL] [Abstract][Full Text] [Related]
12. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
Vartdal F; Johansen BH; Friede T; Thorpe CJ; Stevanović S; Eriksen JE; Sletten K; Thorsby E; Rammensee HG; Sollid LM
Eur J Immunol; 1996 Nov; 26(11):2764-72. PubMed ID: 8921967
[TBL] [Abstract][Full Text] [Related]
13. Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201.
Koelle DM; Johnson ML; Ekstrom AN; Byers P; Kwok WW
Hum Immunol; 1997 Apr; 53(2):195-205. PubMed ID: 9129979
[TBL] [Abstract][Full Text] [Related]
14. A genetically controlled pairing anomaly between HLA-DQ alpha and HLA-DQ beta chains.
Kwok WW; Thurtle P; Nepom GT
J Immunol; 1989 Dec; 143(11):3598-601. PubMed ID: 2479684
[TBL] [Abstract][Full Text] [Related]
15. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition.
Zanelli E; Krco CJ; David CS
J Immunol; 1997 Apr; 158(7):3545-51. PubMed ID: 9120317
[TBL] [Abstract][Full Text] [Related]
16. Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.
Verreck FA; van de Poel A; Termijtelen A; Amons R; Drijfhout JW; Koning F
Eur J Immunol; 1994 Feb; 24(2):375-9. PubMed ID: 8299686
[TBL] [Abstract][Full Text] [Related]
17. Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity.
Khalil-Daher I; Boisgérault F; Feugeas JP; Tieng V; Toubert A; Charron D
Eur J Immunol; 1998 Nov; 28(11):3840-9. PubMed ID: 9842927
[TBL] [Abstract][Full Text] [Related]
18. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice.
Krco CJ; Watanabe S; Harders J; Griffths MM; Luthra H; David CS
J Immunol; 1999 Aug; 163(3):1661-5. PubMed ID: 10415072
[TBL] [Abstract][Full Text] [Related]
19. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
Nepom BS; Nepom GT; Coleman M; Kwok WW
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969
[TBL] [Abstract][Full Text] [Related]
20. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes.
Yu B; Gauthier L; Hausmann DH; Wucherpfennig KW
Eur J Immunol; 2000 Sep; 30(9):2497-506. PubMed ID: 11009082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
